Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Psoriatic 1

Interventions

Specimen Handling 134 pembrolizumab 123 Magnetic Resonance Spectroscopy 112 Carboplatin 88 Cyclophosphamide 82 Biopsy 75 Cisplatin 61 Bevacizumab 59 Paclitaxel 58 Gemcitabine 57 Nivolumab 53 fludarabine 46 Rituximab 41 atezolizumab 39 Pemetrexed 38 Fluorouracil 38 Docetaxel 38 Dexamethasone 38 Doxorubicin 35 Radiotherapy 33 Leucovorin 33 Capecitabine 33 venetoclax 32 Prednisone 32 Oxaliplatin 31 Temozolomide 30 130-nm albumin-bound paclitaxel 29 Standard of Care 27 Cetuximab 27 durvalumab 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × risankizumab × 30 days × Clear all

NCT06641089 2026-06-12

IZAR-2

MoonLake Immunotherapeutics AG

Phase 3 Recruiting

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡